Abstract
THE HER4/ERBB4 gene encodes a 180K transmembrane protein (HER4/pl80erbB4 that is structurally related to the 185K product (HERl/pl85erbB2 of the HER2/ERBB2 proto-oncogene1. A 45K heparin-binding glycoprotein (p45) has been characterized that specifically activates the intrinsic tyrosine kinase activity of HER4 (ref. 2). This HER4 ligand shares several features with the heregulin family of proteins, including molecular mass, ability to induce differentiation of breast cancer cells, activation of tyrosine phosphorylation in MDA-MB453 cells, and amino-terminal protein sequence. Heregulin exists as multiple isoforms and all are presumed to interact directly with HER2 (refs 3–6). We have used binding and phosphorylation studies with recombinant ligand on cell lines expressing recombinant receptors, and report here that heregulin, like p45, is a specific ligand for HER4. Furthermore, heregulin fails to induce phosphorylation of HER2 in the absence of HER4. These findings suggest that activation of the HER4 receptor is involved in signal transduction by heregulin.
Similar content being viewed by others
References
Plowman, G. D. et al. Proc. natn. Acad. Sci. U.S.A. 90, 1746–1750 (1993).
Culouscou, J.-M. et al. J. biol. Chem. 268, 18407–18410 (1993).
Wen, D. et al. Cell 69, 559–572 (1992).
Holmes, W. E. et al. Science 256, 1205–1210 (1992).
Falls, D. L. et al. Cell 72, 801–815 (1993).
Marchionni, M. A. et al. Nature 362, 312–318 (1993).
Lupu, R. et al. Science 249, 1552–1555 (1990).
Lupu, R. et al. Proc. natn. Acad. Sci. U.S.A. 89, 2287–2291 (1992).
Peles, E. et al. EMBO J. 12, 961–971 (1993).
Lax, I. et al. Molec. cell. Biol. 8, 1970–1978 (1988).
Stancovski, I. et al. Proc. natn. Acad. Sci. U.S.A. 88, 8691–8695 (1991).
Seed, B. & Aruffo, A. Proc. natn. Acad. Sci. U.S.A. 84, 3365–3369 (1987).
Plowman, G. D. et al. Molec. cell. Biol. 10, 1969–1981 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Plowman, G., Green, J., Culouscou, JM. et al. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 366, 473–475 (1993). https://doi.org/10.1038/366473a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/366473a0
- Springer Nature Limited
This article is cited by
-
ErbB2-intronic MicroRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling
Cell Death & Disease (2015)
-
HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice
Cancer Gene Therapy (2012)
-
Cross-talk and modulation of signaling between somatostatin and growth factor receptors
Endocrine (2011)
-
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
Breast Cancer Research (2010)
-
Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancer
Breast Cancer Research (2009)